2018 annual financial data
Enliven Therapeutics 2018 Operating margin
Enliven Therapeutics 2018 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -10,677,000 USD and net income was -11,337,000 USD.
Operating cash flow was -8,777,000 USD.
Get free Enliven Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -10,677,000 USD
- Net income
- -11,337,000 USD
- Operating cash flow
- -8,777,000 USD